RADIESSE VOICE INJECTABLE IMPLANT 1011675

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2009-01-02 for RADIESSE VOICE INJECTABLE IMPLANT 1011675 manufactured by Bioform Medical.

Event Text Entries

[1020689] Pt rec'd radiesse voice injectable implant by surgeon and almost immediately noted to have drop in bp. No wheezes or hives but bp treated with vasopressors and epi as well as solumedrol, benadryl, zantac. The pt had nka noted but did receive cefazolin 1 gm ivp 5 min prior to the voice injectable implant injection. Dose or amount: 2 syringes (2ml). Frequency: once. Route: 039. Date of use: 2008. Diagnosis or reason for use: glottic incompetence.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report NumberMW5009513
MDR Report Key1277372
Date Received2009-01-02
Date of Report2008-12-16
Date of Event2008-12-16
Date Added to Maude2009-01-16
Event Key0
Report Source CodeVoluntary report
Manufacturer LinkN
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag0
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Single Use0
Previous Use Code0
Event Type3
Type of Report3

Device Details

Brand NameRADIESSE VOICE INJECTABLE IMPLANT
Generic NameRADIESSE VOICE INJECTABLE IMPLANT
Product CodeMIX
Date Received2009-01-02
Model Number1011675
ID Number8044MO
Device Expiration Date2010-10-01
Device AvailabilityN
Device Sequence No1
Device Event Key0
ManufacturerBIOFORM MEDICAL


Patients

Patient NumberTreatmentOutcomeDate
101. Life Threatening 2009-01-02

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.